Table 2.
Adverse events associated with wPTX + RAM therapy
Adverse events | n = 66 |
---|---|
Neutropenia ≥ grade 3 | 36 (54.5) |
Neutropenia grade 4 | 21 (31.8) |
Febrile neutropenia ≥ grade 3 | 12 (18.2) |
Thrombocytopenia ≥ grade 3 | 3 (4.5) |
Anemia ≥ grade 3 | 11 (16.7) |
AST increased ≥ grade 3 | 3 (4.5) |
ALT increased ≥ grade 3 | 1 (1.5) |
Nausea ≥ grade 3 | 0 (0.0) |
Vomiting ≥ grade 3 | 0 (0.0) |
Anorexia ≥ grade 3 | 1 (1.5) |
Neuropathy ≥ grade 3 | 2 (3.0) |
Mucositis ≥ grade 3 | 2 (3.0) |
Constipation ≥ grade 3 | 0 (0.0) |
Diarrhea ≥ grade 3 | 0 (0.0) |
Hypertension ≥ grade 3 | 2 (3.0) |
Proteinuria ≥ grade 3 | 2 (3.0) |
Data are shown as n (%)
AST Aspartate transaminase, ALT Alanine transaminase